ZYCRISSE
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ZYCRISSE Trademark

Serial Number: 97010820

ZYCRISSE is a trademark filed by Neurocrine Biosciences, Inc. on September 3, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Neurocrine Biosciences, Inc. (237 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

September 3, 2021

Registration Date

Not Registered

Published for Opposition

December 6, 2022

Goods & Services

pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 8, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 8, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jul 24, 2024 EX3G
SOU EXTENSION 3 FILED
Jul 24, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 24, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 25, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jan 23, 2024 EX2G
SOU EXTENSION 2 FILED
Jan 23, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 23, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 28, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jul 26, 2023 EX1G
SOU EXTENSION 1 FILED
Jul 26, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 26, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 31, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 6, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 6, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 16, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 2, 2022 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 2, 2022 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 9, 2022 GPRN
PRIORITY ACTION E-MAILED
May 9, 2022 GPRA
PRIORITY ACTION WRITTEN
May 9, 2022 CPRA
ASSIGNED TO EXAMINER
May 3, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2021 NWOS
NEW APPLICATION ENTERED
Sep 7, 2021 NWAP